In the highly active antiretroviral therapy (HAART) era, the incidence of non-AIDS-defining
cancers (NADC) has increased and contributes to a growing proportion of mortality in the …

With the advent of effective combination antiretroviral therapy, HIV infection has been
transformed from a fatal disease to a chronic condition. There is renewed clinical interest in …

Background. People living with HIV (PLHIV) are at a high‐risk of developing AIDS‐defining
cancers (ADCs) and non‐AIDS‐defining cancers (NADCs). This review is aimed at exploring …

Highly active antiretroviral therapy (HAART) for human immunodeficiency virus (HIV)
infection has been widely available in industrialized countries since 1996; its widespread …

Highly active antiretroviral therapy (HAART) for human immunodeficiency virus (HIV)
infection has been widely available in industrialized countries since 1996; its widespread …

Purpose of review The introduction of antiretroviral therapy (ART) has revolutionized HIV
infection management, resulting in improved outcomes and survival for people living with …

It is unclear whether the growing number of reports on non-AIDS-defining cancers reflects a
true increased incidence or merely the product of increased surveillance, detection and …

Non-AIDS-defining malignancies account for more morbidity and mortality than AIDS-
defining malignancies in the antiretroviral therapy era. Traditional risk factors play a …

Much has been written about the increase in non–AIDS-defining cancers in HIV-infected
persons over the past decade. 1-8 It is now clear that cancers other than AIDS-defining …

In the highly active antiretroviral therapy (HAART) era, the incidence of AIDS-defining
malignancies (ADMs) has declined significantly. On the other hand, the incidence of other …